Sangamo Therapeutics, Inc

CHARLES SCHWAB INVESTMENT MANAGEMENT INC SGMO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,713,331

Value ($000)

720

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	720	0.0%	1,713,331	12/31/2025
2025 Q3	11/10/2025	1,036	0.0%	1,538,998	9/30/2025
2025 Q2	8/12/2025	694	0.0%	1,281,799	6/30/2025
2025 Q1	9/15/2025	720	0.0%	1,097,834	3/31/2025
2024 Q4	2/6/2025	1,162	0.0%	1,139,252	12/31/2024
2024 Q3	11/12/2024	956	0.0%	1,103,326	9/30/2024
2024 Q2	8/12/2024	375	0.0%	1,046,201	6/30/2024
2024 Q1	5/9/2024	832	0.0%	1,242,131	3/31/2024
2023 Q4	2/6/2024	656	0.0%	1,206,879	12/31/2023
2023 Q3	11/8/2023	714	0.0%	1,191,202	9/30/2023
2023 Q2	8/10/2023	1,214	0.0%	933,526	6/30/2023
2023 Q1	5/12/2023	1,784	0.0%	1,013,774	3/31/2023
2022 Q4	2/13/2023	3,185	0.0%	1,014,392	12/31/2022
2022 Q3	11/14/2022	4,607	0.0%	940,174	9/30/2022
2022 Q2	8/15/2022	3,631	0.0%	876,884	6/30/2022
2022 Q1	5/13/2022	5,130	0.0%	882,914	3/31/2022
2021 Q4	2/11/2022	6,373	0.0%	849,644	12/31/2021
2021 Q3	11/16/2021	8,464	0.0%	939,334	9/30/2021
2021 Q2	8/16/2021	10,929	0.0%	912,994	6/30/2021
2021 Q1	5/17/2021	11,136	0.0%	888,704	3/31/2021
2020 Q4	2/16/2021	13,266	0.0%	850,088	12/31/2020
2020 Q3	11/13/2020	7,334	0.0%	776,053	9/30/2020
2020 Q2	8/20/2020	6,957	0.0%	776,407	6/30/2020
2020 Q1	5/15/2020	4,635	0.0%	727,490	3/31/2020
2019 Q4	2/7/2020	6,004	0.0%	717,309	12/31/2019
2014 Q2	7/30/2014	2,893	0.0%	189,428	6/30/2014
2014 Q1	4/29/2014	3,113	0.0%	172,132	3/31/2014
2013 Q4	2/14/2014	2,252	0.0%	162,120	12/31/2013